Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets

This study is observing how well a combination diabetes pill (proline plus empagliflozin) works in real-world patients with type 2 diabetes, tracking blood sugar control and other health outcomes over time. **You may be eligible if...** - You are 18 or older - You have been clinically diagnosed with type 2 diabetes - Your doctor has decided to prescribe this specific medication (Hui You Jing / proline-empagliflozin tablet) for the first time - You have had a recent HbA1c (3-month blood sugar average) test within the past 4 weeks - You are willing to participate voluntarily **You may NOT be eligible if...** - You have moderate to severe kidney disease (eGFR below 30) or are on dialysis - You have diabetic ketoacidosis (a serious diabetes complication) or a history of it - You are severely allergic to this medication - You are currently in another clinical trial Talk to your doctor to see if this trial is right for you.